Literature DB >> 12691684

Prevalence and correlates of fatigue among persons with HIV infection.

Patrick S Sullivan1, Mark S Dworkin.   

Abstract

To describe prevalence of fatigue and its correlates among persons with HIV infection, we abstracted medical records of 13,768 persons in care for HIV in >100 US clinics. The prevalence of fatigue (defined as fatigue, malaise, or weakness that was the primary reason for a medical visit, was persistent, or was severe enough to preclude work) was 37%. Fatigue was more common among persons with clinical AIDS (adjusted odds ratio [AOR] 1.3, CI 1.1-1.5); depression (AOR 2.4, CI 2.1-2.7); and hemoglobin concentrations <8, 8-10, and 10-12 g/dL (AORs 3.3 [CI 2.4-4.6], 2.7 [CI 2.2-3.2], and 1.5 [CI 1.3-1.7], respectively). Fatigue was not associated with viral load or CD4 cell count <200/microl. Fatigue cannot be viewed solely as a constitutional symptom of progressive HIV disease. Physicians should seek underlying, treatable causes for fatigue such as depression and anemia and treat these conditions when they are found.

Entities:  

Mesh:

Year:  2003        PMID: 12691684     DOI: 10.1016/s0885-3924(02)00676-0

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  23 in total

1.  Clinical, laboratory, and neuroimaging characteristics of fatigue in HIV-infected individuals.

Authors:  Giovanni Schifitto; Lijuan Deng; Tzu-Min Yeh; Scott R Evans; Thomas Ernst; Jianhui Zhong; David Clifford
Journal:  J Neurovirol       Date:  2010-12-23       Impact factor: 2.643

2.  Patterns of morning and evening fatigue among adults with HIV/AIDS.

Authors:  Anners Lerdal; Caryl L Gay; Bradley E Aouizerat; Carmen J Portillo; Kathryn A Lee
Journal:  J Clin Nurs       Date:  2011-08       Impact factor: 3.036

3.  Demographic and illness-related variables associated with HIV-related fatigue.

Authors:  James L Harmon; Julie Barroso; Brian Wells Pence; Jane Leserman; Naima Salahuddin
Journal:  J Assoc Nurses AIDS Care       Date:  2008 Mar-Apr       Impact factor: 1.354

4.  Age and racial/ethnic differences in the prevalence of reported symptoms in human immunodeficiency virus-infected persons on antiretroviral therapy.

Authors:  Michael J Silverberg; Lisa P Jacobson; Audrey L French; Mallory D Witt; Stephen J Gange
Journal:  J Pain Symptom Manage       Date:  2009-03-28       Impact factor: 3.612

5.  Physiological and psychosocial factors that predict HIV-related fatigue.

Authors:  Julie Barroso; Bradley G Hammill; Jane Leserman; Naima Salahuddin; James L Harmon; Brian Wells Pence
Journal:  AIDS Behav       Date:  2010-12

6.  A 7-item version of the fatigue severity scale has better psychometric properties among HIV-infected adults: an application of a Rasch model.

Authors:  Anners Lerdal; Anders Kottorp; Caryl Gay; Bradley E Aouizerat; Carmen J Portillo; Kathryn A Lee
Journal:  Qual Life Res       Date:  2011-03-10       Impact factor: 4.147

7.  Cytokine polymorphisms are associated with fatigue in adults living with HIV/AIDS.

Authors:  Kathryn A Lee; Caryl L Gay; Anners Lerdal; Clive R Pullinger; Bradley E Aouizerat
Journal:  Brain Behav Immun       Date:  2014-03-12       Impact factor: 7.217

8.  Somatic symptoms and the association between hepatitis C infection and depression in HIV-infected patients.

Authors:  Jeanie C Yoon; Paul K Crane; Paul S Ciechanowski; Robert D Harrington; Mari M Kitahata; Heidi M Crane
Journal:  AIDS Care       Date:  2011-05-23

9.  Fatigue-related gene networks identified in CD(14)+ cells isolated from HIV-infected patients: part I: research findings.

Authors:  Joachim G Voss; Adrian Dobra; Caryn Morse; Joseph A Kovacs; Robert L Danner; Peter J Munson; Carolea Logan; Zoila Rangel; Joseph W Adelsberger; Mary McLaughlin; Larry D Adams; Raghavan Raju; Marinos C Dalakas
Journal:  Biol Res Nurs       Date:  2013-01-16       Impact factor: 2.522

10.  Lack of energy: an important and distinct component of HIV-related fatigue and daytime function.

Authors:  Bradley E Aouizerat; Caryl L Gay; Anners Lerdal; Carmen J Portillo; Kathryn A Lee
Journal:  J Pain Symptom Manage       Date:  2012-08-20       Impact factor: 3.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.